Clinical TrialsSearch results
Number of results: 2443
Other
- Cancer therapy with vaccination using HLA-A02 restricted peptide from human vascular endothelial growth factor receptor 2: a phase I study patients with unresectable colorectal cancer
- unresectable colorectal cancer
- Institute of Medical Science, University of Tokyo
- 2007-05-02
Other
- Cancer therapy with vaccination using HLA-A02-restricted peptide from RNF43: a phase I study in patients with unresectable colorectal cancer
- unresectable colorectal cancer
- Institute of Medical Science The University of Tokyo
- 2007-05-10
Other
- Cancer therapy with vaccination using HLA-A24-restricted peptide from human vascular endothelial growth factor receptor 2: a phase I study in patients with unresectable colorectal cancer
- unresectable colorectal cancer
- Institute of Medical Science, University of Tokyo
- 2007-05-02
Other
- Cancer therapy with vaccination using HLA-A24-restricted peptide from RNF43:a phase I study in patients with unresectable colorectal cancer
- unresectable colorectal cancer
- Institute of Medical Science, University of Tokyo
- 2007-05-07
Other
- Cancer therapy with vaccination using HLA-A24-restricted peptide from TOMM34:a phase I study in patients with unresectable colorectal cancer
- unresectable colorectal cancer
- Institute of Medical Science, University of Tokyo
- 2007-07-30
Other
- Phase I clinical trial of epitope peptides based vaccines both targeting RNF43 and VEGFR2 in patients with advanced colorectal cancer.
- unresectable colorectal cancer
- Institute of Medical Science The University of Tokyo
- 2007-12-23
Recruiting
- A phase II study by using CICS-1 and SPM-011 commissioned by CICS and STELLA PHARMA
- Unresectable angiosarcoma
- Hayashi Toshimitsu
- 2022-10-26
Not yet recruiting
- Correlation between prognosis and expressions of Mcl-1(Myeloid cell leukemia-1) and Stat-3(signal transducers and activator of transcription-3) in patients with metastasized or recurrent gastrointestinal malignancy
- Unresectable and recurrent gastric or colorectal carcinoma
- Keio University School of Medicine
- 2008-11-01
Other
- NCCH1907/MK008 trial
- unresectable alveolar soft tissue sarcoma
- Yonemori Kan
- 2020-06-01
Other
- Phase II study of Bevacizumab plus modified OPTIMOX1 in patients with unresectable advanced/recurrent colorectal cancer
- Unresectable advanced/recurrent colorectal cancer
- The Tokyo Cooperative Oncology Group
- 2008-06-01